TABLE 1.

Subject cohort^a

Subject	Age	Gender	Duration of infection(days)	Baseline CD4	pVL	Baseline BAL % lymphocyte	Prior lung disease
3001	38	M	4,800	430	67,583	17	Pneumonia
3002	56	M	50	37	85,208	20	PCP
3003	28	M	50	25	24,656	10
3005	48	M	1,700	92	99,787	15	Pneumonia
3006	49	M	100	184	31,900	20
3007	37	M	200	48	750,000	16
3008	45	M	2,200	385	64,200	5
3009	47	M	2,800	395	53,400	1	Pneumonia
3010	50	F	100	48	3,480	1	Pneumonia
3011	43	F	350	814	23,800	12
3012	36	M	1,300	296	24,100	2
3014	24	M	50	286	100,000	25
3015	37	M	100	308	51,100	4	Asthma
3016	46	M	4,500	188	100,000	24
3017	49	M	2,600	649	100,000	15
3018	23	M	400	296	750,000	30
3019	46	M	5,600	16	100,000	51
3021	50	F	1,000	450	7,270	12
3022	51	M	5,200	277	46,400	9	Pneumonia
3023	43	M	700	440	94,750	19

^apVL, plasma viral load; baseline, day 0 relative to HAART; PCP, Pnuemocystis pneumonia; M, male; F, female. CD4 counts are given as cells/μl blood. HIV duration is an approximation at the baseline.